Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Frank

Showing results (11-20 of 153) with videos related to

Pageof 16
Sort By:
The Journal of Infectious Diseases|March 11, 2014
Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cellsLorenzo A Ramirez, Alexander Daniel, Ian Frank, et al.
Journal of Virology|August 21, 2002
Development of a human neuronal cell model for human immunodeficiency virus (HIV)-infected macrophage-induced neurotoxicity: apoptosis induced by HIV type 1 primary isolates and evidence for involvement of the Bcl-2/Bcl-xL-sensitive intrinsic apoptosis pathwayWei Chen, Jerrold Sulcove, Ian Frank, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 1, 2008
Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in BotswanaGregory P Bisson, Adam Rowh, Rachel Weinstein, et al.
Retina (Philadelphia, Pa.)|January 26, 2018
BETA-D-GLUCAN TESTING IN PATIENTS WITH FUNGAL ENDOPHTHALMITISAnton M Kolomeyer, Kathleen M Murphy, Anastasia Traband, et al.
Optics Express|October 17, 2014
Surface plasmon polariton enhanced ultrathin nano-structured CdTe solar cellTing S Luk, Nche T Fofang, Jose L Cruz-Campa, et al.
Journal of the International Association of Providers of AIDS Care|April 19, 2018
Is Tobacco Use Associated with Neurocognitive Dysfunction in Individuals with HIV?Billy Tsima, Sarah Jane Ratcliffe, Robert Schnoll, et al.
JAMIA Open|November 16, 2022
Using a patient portal as a recruitment tool to diversify the pool of participants in COVID-19 vaccine clinical trialsTiffany Yuh, Tuhina Srivastava, Danielle Fiore, et al.
AIDS Care|November 24, 2011
Impact of transitioning from HIV clinical trials to routine medical care on clinical outcomes and patient perceptionsBaligh R Yehia, Judith A Long, Cordelia R Stearns, et al.
AIDS (London, England)|December 13, 2001
Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infectionsGiuseppe Nunnari, Miguel Otero, Geethanjali Dornadula, et al.
Health Marketing Quarterly|November 8, 2011
An exploratory study of adolescent female reactions to direct-to-consumer advertising: the case of the Human Papillomavirus (HPV) VaccineAmy E Leader, Rebecca Cashman, Chelsea D Voytek, et al.
Pageof 16

Showing results (11-20 of 153) with videos related to

Sort By:
Pageof 16
The Journal of Infectious Diseases|March 11, 2014
Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cellsLorenzo A Ramirez, Alexander Daniel, Ian Frank, et al.
Journal of Virology|August 21, 2002
Development of a human neuronal cell model for human immunodeficiency virus (HIV)-infected macrophage-induced neurotoxicity: apoptosis induced by HIV type 1 primary isolates and evidence for involvement of the Bcl-2/Bcl-xL-sensitive intrinsic apoptosis pathwayWei Chen, Jerrold Sulcove, Ian Frank, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 1, 2008
Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in BotswanaGregory P Bisson, Adam Rowh, Rachel Weinstein, et al.
Retina (Philadelphia, Pa.)|January 26, 2018
BETA-D-GLUCAN TESTING IN PATIENTS WITH FUNGAL ENDOPHTHALMITISAnton M Kolomeyer, Kathleen M Murphy, Anastasia Traband, et al.
Optics Express|October 17, 2014
Surface plasmon polariton enhanced ultrathin nano-structured CdTe solar cellTing S Luk, Nche T Fofang, Jose L Cruz-Campa, et al.
Journal of the International Association of Providers of AIDS Care|April 19, 2018
Is Tobacco Use Associated with Neurocognitive Dysfunction in Individuals with HIV?Billy Tsima, Sarah Jane Ratcliffe, Robert Schnoll, et al.
JAMIA Open|November 16, 2022
Using a patient portal as a recruitment tool to diversify the pool of participants in COVID-19 vaccine clinical trialsTiffany Yuh, Tuhina Srivastava, Danielle Fiore, et al.
AIDS Care|November 24, 2011
Impact of transitioning from HIV clinical trials to routine medical care on clinical outcomes and patient perceptionsBaligh R Yehia, Judith A Long, Cordelia R Stearns, et al.
AIDS (London, England)|December 13, 2001
Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: latency without on-going cellular infectionsGiuseppe Nunnari, Miguel Otero, Geethanjali Dornadula, et al.
Health Marketing Quarterly|November 8, 2011
An exploratory study of adolescent female reactions to direct-to-consumer advertising: the case of the Human Papillomavirus (HPV) VaccineAmy E Leader, Rebecca Cashman, Chelsea D Voytek, et al.
Pageof 16